Evidence map›Paper›PMID 42614741›Full record

ReviewFrontiers in immunology2026

Immune cell dynamics and cytokine regulation in cornea and transplantation.

Ankur Sharma, Ahmad Ai Aiyan, Uday Kishore

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ankur SharmaDepartment of Veterinary Medicine, United Arab Emirates University, Al Ain, United Arab Emirates.
Ahmad Ai AiyanDepartment of Veterinary Medicine, United Arab Emirates University, Al Ain, United Arab Emirates.
Uday KishoreDepartment of Veterinary Medicine, United Arab Emirates University, Al Ain, United Arab Emirates.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immune privilege is essential for clear vision in the cornea. It assists in maintaining a strong defense against pathogens while limiting inflammation. This advantage results from a combination of physical barriers, such as the blood-eye barrier, local anti-inflammatory molecules, T cell apoptosis, resident and infiltrating immune cells, cytokine network, and humoral factors. These dynamic processes collaborate to protect the cornea and prevent tissue damage. While the development of ocular T regulatory cells is well-known, the specific mechanisms through which they suppress immune-mediated inflammation are not fully characterized. Recent advances in imaging and molecular biology have revealed the dynamic behavior of corneal immune cells and their regulatory roles in the production of cytokines and other humoral mediators. This review summarizes existing knowledge on corneal immune cell dynamics, cytokine regulation, and the mechanisms that support immune privilege and its rejection in corneal transplantation. We highlight the continuing discussions, identifying research shortcomings, and innovative therapeutic approaches targeting these pathways to improve graft viability and address corneal inflammatory diseases.

Indexed as

CorneaCorneal TransplantationCytokinesAnimalsGraft RejectionHumansImmune PrivilegeCytokinescomplementcorneacytokinesimmune receptorsocular immunitytransplantation

Identifiers

PMID42614741
PMCPMC13482458

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.